Sponsor

Anaptysbio Inc.

United States 10770 Wateridge Circle Suite 210, 92121-5801, United States

About the sponsor

Clinical research in atopic dermatitis focuses on immune-mediated skin inflammation and persistent pruritus, with attention to disease control in moderate to severe cases.

Atopic dermatitis
Immune dysregulation
Chronic pruritic dermatitis

The sponsor’s portfolio places substantial emphasis on dermatologic inflammation and conditions driven by aberrant immune signaling.

About Specializations

Anaptysbio Inc. runs clinical trials in conditions such as Dermatitis atopic, Colitis ulcerative, Rheumatoid arthritis, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

4 clinical trials

Dermatitis atopic

Not yet recruiting

Study on the Effectiveness and Safety of ANB032, Hydrocortisone, and Alclometasone Dipropionate for Patients with Moderate to Severe Atopic Dermatitis

Registered drug

Study on the Effectiveness and Safety of ANB032, Hydrocortisone, and Alclometasone Dipropionate for Patients with Moderate to Severe Atopic Dermatitis

Registered drug

Czechia

Participants:18–64 years
Substances:ANB032
Sponsor:Anaptysbio Inc.

Contact Research Centre

Dermatitis atopic

Not recruiting

Study on the Effectiveness and Safety of ANB032, Betamethasone Dipropionate, and Hydrocortisone for Patients with Moderate to Severe Atopic Dermatitis

Registered drug